ABIN610270
antibody from antibodies-online
Targeting: LTBR
D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN610270 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lymphotoxin beta Receptor (TNFR Superfamily, Member 3) (LTBR) antibody (PE)
- Antibody type
- Monoclonal
- Description
- Gel filtration
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- ANCLTR2-9E2
- Vial size
- 120 tests
- Storage
- Store at 4°C. Do not freeze. Protect from light.
- Handling
- Do not freeze. Product is photosensitive and should be protected from light.
Submitted references Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver.
Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology.
Seki N, Takasu T, Mandai K, Nakata M, Saeki H, Heike Y, Takata I, Segawa Y, Hanafusa T, Eguchi K
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Oct;8(10):3046-53
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Oct;8(10):3046-53
Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver.
Jiang YP, Ballou LM, Lin RZ
The Journal of biological chemistry 2001 Apr 6;276(14):10943-51
The Journal of biological chemistry 2001 Apr 6;276(14):10943-51
Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology.
De Benedetti A, Rhoads RE
Proceedings of the National Academy of Sciences of the United States of America 1990 Nov;87(21):8212-6
Proceedings of the National Academy of Sciences of the United States of America 1990 Nov;87(21):8212-6
No comments: Submit comment
No validations: Submit validation data